
<DOC>
<DOCNO>
WSJ900423-0091
</DOCNO>
<DOCID>
900423-0091.
</DOCID>
<HL>
   Who's News:
   Two of Epitope Inc.'s
   Founders, Its Chairman
   And President, Resign
</HL>
<DATE>
04/23/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B7
</SO>
<CO>
   WNEWS EPT
</CO>
<LP>
   BEAVERTON, Ore. -- Epitope Inc. said two of its three
founders, Denis R. Burger, chairman, and Michael C. Hubbard,
president and chief executive officer, resigned to pursue
other business interests.
   The biotechnology concern said it named Roger Pringle
chairman and Adolph J. Ferro president and chief executive
officer. Mr. Pringle was an Epitope director; Mr. Ferro was
formerly president of the company's Agritope Inc. unit.
</LP>
<TEXT>
   Mr. Burger left to pursue full-time operation of Yamhill
Valley Vineyard and his related wine-distribution business.
He will remain a member of the board, and will serve as a
consultant. Mr. Hubbard will pursue other unspecified
business interests, the company said. He also will remain as
a consultant.
   A third founder, Andrew Goldstein, remains with the
company as vice president, product development.
   Epitope is developing diagnostic tests for AIDS as well as
therapeutic drugs for protozoan diseases. The company also is
developing genetically engineered plant varieties through its
Agritope subsidiary.
   In its fiscal first quarter ended Dec. 31, the company
posted a net loss of $541,000, or eight cents a share, on
revenue of about $1 million. It had a loss of $870,000, or 18
cents a share, on revenue of $544,000 the year earlier.
</TEXT>
</DOC>